RelB EMSA status and characteristics of the 66 de novo DLBCL patients
| Patient no. . | COO . | Age, y . | Sex . | IPI . | RelB EMSA status . |
|---|---|---|---|---|---|
| 1 | GCB | 43 | Male | 0 | NEG |
| 2 | ABC | 55 | Female | 1 | POS |
| 3 | ABC | 66 | Male | 4 | POS |
| 4 | ABC | 61 | Female | 3 | POS |
| 5 | ABC | 65 | Female | 5 | POS |
| 6 | GCB | 52 | Male | 2 | POS |
| 7 | ABC | 76 | Female | 4 | POS |
| 8 | ABC | 61 | Male | 3 | POS |
| 9 | ABC | 66 | Male | 3 | POS |
| 10 | ABC | 83 | Female | 4 | NEG |
| 11 | ABC | 43 | Female | 4 | NEG |
| 12 | ABC | 58 | Male | 3 | POS |
| 13 | ABC | 66 | Female | 3 | NEG |
| 14 | ABC | 68 | Female | 4 | POS |
| 15 | GCB | 60 | Male | 4 | POS |
| 16 | ABC | 76 | Female | 3 | POS |
| 17 | ABC | 76 | Female | 5 | POS |
| 18 | ABC | 87 | Male | 5 | POS |
| 19 | ABC | 56 | Male | 1 | NEG |
| 20 | GCB | 70 | Male | 2 | POS |
| 21 | ABC | 66 | Male | 3 | NEG |
| 22 | GCB | 49 | Female | 3 | POS |
| 23 | ABC | 26 | Female | 1 | POS |
| 24 | ABC | 38 | Male | 1 | POS |
| 25 | ABC | 78 | Female | 4 | NEG |
| 26 | GCB | 46 | Female | 0 | NEG |
| 27 | GCB | 38 | Male | 0 | POS |
| 28 | GCB | 53 | Female | 3 | NEG |
| 29 | ABC | 54 | Female | 0 | NEG |
| 30 | ABC | 50 | Female | 2 | NEG |
| 31 | ABC | 72 | Male | 4 | NEG |
| 32 | ABC | 76 | Female | 2 | POS |
| 33 | ABC | 53 | Female | 1 | POS |
| 34 | GCB | 20 | Male | 1 | POS |
| 35 | GCB | 61 | Male | 1 | POS |
| 36 | GCB | 72 | Male | 2 | NEG |
| 37 | ABC | 55 | Female | 1 | NEG |
| 38 | ABC | 55 | Male | 3 | NEG |
| 39 | ABC | 67 | Male | 2 | POS |
| 40 | ABC | 61 | Female | 5 | POS |
| 41 | ABC | 80 | Male | 5 | POS |
| 42 | ABC | 65 | Female | 4 | POS |
| 43 | GCB | 24 | Female | 0 | POS |
| 44 | GCB | 26 | Male | 2 | NEG |
| 45 | GCB | 39 | Female | 4 | POS |
| 46 | ABC | 75 | Male | 5 | POS |
| 47 | ABC | 63 | Female | 5 | POS |
| 48 | ABC | 24 | Male | 1 | POS |
| 49 | GCB | 48 | Female | 4 | POS |
| 50 | GCB | 68 | Female | 3 | NEG |
| 51 | ABC | 81 | Female | 5 | POS |
| 52 | ABC | 81 | Male | 3 | NEG |
| 53 | ABC | 52 | Female | 1 | POS |
| 54 | ABC | 59 | Female | 1 | POS |
| 55 | ABC | 52 | Female | 1 | NEG |
| 56 | GCB | 44 | Female | 3 | POS |
| 57 | GCB | 77 | Female | 3 | POS |
| 58 | ABC | 58 | Female | 0 | POS |
| 59 | GCB | 51 | Female | 3 | POS |
| 60 | GCB | 52 | Female | 2 | NEG |
| 61 | GCB | 62 | Male | 3 | POS |
| 62 | ABC | 83 | Male | 4 | POS |
| 63 | GCB | 50 | Male | 2 | POS |
| 64 | GCB | 61 | Male | 1 | NEG |
| 65 | GCB | 53 | Male | 1 | NEG |
| 66 | GCB | 32 | Female | 1 | POS |
| Patient no. . | COO . | Age, y . | Sex . | IPI . | RelB EMSA status . |
|---|---|---|---|---|---|
| 1 | GCB | 43 | Male | 0 | NEG |
| 2 | ABC | 55 | Female | 1 | POS |
| 3 | ABC | 66 | Male | 4 | POS |
| 4 | ABC | 61 | Female | 3 | POS |
| 5 | ABC | 65 | Female | 5 | POS |
| 6 | GCB | 52 | Male | 2 | POS |
| 7 | ABC | 76 | Female | 4 | POS |
| 8 | ABC | 61 | Male | 3 | POS |
| 9 | ABC | 66 | Male | 3 | POS |
| 10 | ABC | 83 | Female | 4 | NEG |
| 11 | ABC | 43 | Female | 4 | NEG |
| 12 | ABC | 58 | Male | 3 | POS |
| 13 | ABC | 66 | Female | 3 | NEG |
| 14 | ABC | 68 | Female | 4 | POS |
| 15 | GCB | 60 | Male | 4 | POS |
| 16 | ABC | 76 | Female | 3 | POS |
| 17 | ABC | 76 | Female | 5 | POS |
| 18 | ABC | 87 | Male | 5 | POS |
| 19 | ABC | 56 | Male | 1 | NEG |
| 20 | GCB | 70 | Male | 2 | POS |
| 21 | ABC | 66 | Male | 3 | NEG |
| 22 | GCB | 49 | Female | 3 | POS |
| 23 | ABC | 26 | Female | 1 | POS |
| 24 | ABC | 38 | Male | 1 | POS |
| 25 | ABC | 78 | Female | 4 | NEG |
| 26 | GCB | 46 | Female | 0 | NEG |
| 27 | GCB | 38 | Male | 0 | POS |
| 28 | GCB | 53 | Female | 3 | NEG |
| 29 | ABC | 54 | Female | 0 | NEG |
| 30 | ABC | 50 | Female | 2 | NEG |
| 31 | ABC | 72 | Male | 4 | NEG |
| 32 | ABC | 76 | Female | 2 | POS |
| 33 | ABC | 53 | Female | 1 | POS |
| 34 | GCB | 20 | Male | 1 | POS |
| 35 | GCB | 61 | Male | 1 | POS |
| 36 | GCB | 72 | Male | 2 | NEG |
| 37 | ABC | 55 | Female | 1 | NEG |
| 38 | ABC | 55 | Male | 3 | NEG |
| 39 | ABC | 67 | Male | 2 | POS |
| 40 | ABC | 61 | Female | 5 | POS |
| 41 | ABC | 80 | Male | 5 | POS |
| 42 | ABC | 65 | Female | 4 | POS |
| 43 | GCB | 24 | Female | 0 | POS |
| 44 | GCB | 26 | Male | 2 | NEG |
| 45 | GCB | 39 | Female | 4 | POS |
| 46 | ABC | 75 | Male | 5 | POS |
| 47 | ABC | 63 | Female | 5 | POS |
| 48 | ABC | 24 | Male | 1 | POS |
| 49 | GCB | 48 | Female | 4 | POS |
| 50 | GCB | 68 | Female | 3 | NEG |
| 51 | ABC | 81 | Female | 5 | POS |
| 52 | ABC | 81 | Male | 3 | NEG |
| 53 | ABC | 52 | Female | 1 | POS |
| 54 | ABC | 59 | Female | 1 | POS |
| 55 | ABC | 52 | Female | 1 | NEG |
| 56 | GCB | 44 | Female | 3 | POS |
| 57 | GCB | 77 | Female | 3 | POS |
| 58 | ABC | 58 | Female | 0 | POS |
| 59 | GCB | 51 | Female | 3 | POS |
| 60 | GCB | 52 | Female | 2 | NEG |
| 61 | GCB | 62 | Male | 3 | POS |
| 62 | ABC | 83 | Male | 4 | POS |
| 63 | GCB | 50 | Male | 2 | POS |
| 64 | GCB | 61 | Male | 1 | NEG |
| 65 | GCB | 53 | Male | 1 | NEG |
| 66 | GCB | 32 | Female | 1 | POS |
PI, International Prognostic Index.